Deep Apple Therapeutics
PrivateLast Round
Series A
Dec 14, 2023
Total Funding Raised
$52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Deep Apple Therapeutics is a biotechnology company that develops small-molecule drugs for inflammatory, metabolic, and endocrine diseases using a proprietary discovery engine that integrates cryo-electron microscopy, deep learning, and virtual screening.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deep Apple Therapeutics Comparables
Compare Deep Apple Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Superluminal Medicines | 83% | |
| Terray Therapeutics | 79% | |
| Kallyope | 76% |
Deep Apple Therapeutics Funding Rounds
Historical fundraising activity
Deep Apple Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 120% MoM, reaching 5K.
- Jul 25, 2026
Monthly visitors increased 250% MoM.
Deep Apple Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Deep Apple Therapeutics's valuation, stock price, and market status.
Is Deep Apple Therapeutics a public or private company?
Deep Apple Therapeutics is a private company.
What is the current stock price of Deep Apple Therapeutics?
Deep Apple Therapeutics is a private company, so its shares have no public market price. Caplight tracks Deep Apple Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deep Apple Therapeutics worth (valuation)?
Valuation information for Deep Apple Therapeutics is not publicly available.
Can I buy Deep Apple Therapeutics stock?
Deep Apple Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deep Apple Therapeutics's last funding round?
Deep Apple Therapeutics's most recent funding round was Series A on December 14, 2023.
Who are the main investors in Deep Apple Therapeutics?
Key investors in Deep Apple Therapeutics include Apple Tree Partners.
Will Deep Apple Therapeutics IPO soon?
No public IPO plans have been announced for Deep Apple Therapeutics.
How can I track Deep Apple Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Deep Apple Therapeutics's shares on secondary markets.